🔗 Visit the ClinicalTrials.gov page for NCT01245673
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. | Oncoimmunology | 2012 | 1.88 |
| 2 | Trial watch: Peptide vaccines in cancer therapy. | Oncoimmunology | 2012 | 1.17 |
| 3 | Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells. | Clin Cancer Res | 2014 | 1.01 |
| 4 | Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma. | Bone Marrow Transplant | 2015 | 0.89 |
| 5 | Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. | Oncoimmunology | 2015 | 0.85 |
| 6 | Cancer testis antigen and immunotherapy. | Immunotargets Ther | 2013 | 0.76 |
| 7 | Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens. | Iran J Cancer Prev | 2015 | 0.75 |